CTAS
42
2
NEE
44
3
CVX
17
3
BLK
54
4
DHR
40
5
THC
53
3
ILMN
32
2
STI
35
14
AIG
38
2
ALLE
25
4
ACN
54
4
DFS
70
5
LOW
46
3
MA
64
2
CMS
60
2
NAVI
40
7
PWR
66
3
ABBV
48
2
CRM
67
2
BBY
52
4
CTAS
42
2
NEE
44
3
CVX
17
3
BLK
54
4
DHR
40
5
THC
53
3
ILMN
32
2
STI
35
14
AIG
38
2
ALLE
25
4
ACN
54
4
DFS
70
5
LOW
46
3
MA
64
2
CMS
60
2
NAVI
40
7
PWR
66
3
ABBV
48
2
CRM
67
2
BBY
52
4
Financhill
Back

West Pharmaceutical Services 10K Form

Sell
49

WST
West Pharmaceutical Services

Last Price:
$332.66
Seasonality Move:
6.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-25 10Q WST/West Pharmaceutical Services Quarterly
2023-10-26 10Q WST/West Pharmaceutical Services Quarterly
2023-07-27 10Q WST/West Pharmaceutical Services Quarterly
2023-04-27 10Q WST/West Pharmaceutical Services Quarterly
2022-10-27 10Q WST/West Pharmaceutical Services Quarterly
2022-07-28 10Q WST/West Pharmaceutical Services Quarterly

Receive WST News And Ratings

See the #1 stock for the next 7 days that we like better than WST

WST Financial Statistics

Sales & Book Value

Annual Sales: $2.9B
Cash Flow: $98.8M
Price / Cash Flow: 76.6
Annual Sales: $37.96
Price / Book: 8.76

Profitability

EPS (TTM): 6.74000
Net Income (TTM): $499.6M
Gross Margin: $1.1B
Return on Equity: 18.16%
Return on Assets: 13.61%

West Pharmaceutical Services Earnings Forecast

Key West Pharmaceutical Services Financial Ratios

  • The Gross Profit Margin over the past 40 years for WST is 38.28%.
  • The Selling, General & Administrative Expenses for WST have been equal to 11.98% of Gross Profit Margin.
  • The Research & Development expenses have been 2.32% of Revenue.
  • The Interest Expense is 1.52% of Operating Income.
  • The Net Earning history of WST is 20.12% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 26 years.

West Pharmaceutical Services Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: WST
CUSIP: 955306
Website: westpharma.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 3
Quick Ratio: 1.97

Price-to-Earnings

Trailing P/E Ratio: 42.23
Forward P/E Ratio: 44.38

WST Technical Analysis vs Fundamental Analysis

Sell
49
West Pharmaceutical Services (WST) is a Sell

Is West Pharmaceutical Services a Buy or a Sell?